GO:0019448 L-cysteine catabolic process: Sulfur Amino Acid Breakdown, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019448 (L-cysteine catabolic process) describes the biochemical reactions that break down L-cysteine, a sulfur-containing amino acid.
• L-cysteine catabolism is essential for sulfur homeostasis, taurine and sulfate production, and detoxification via the mercapturic acid pathway.
• Key enzymes include cysteine dioxygenase (CDO), aspartate aminotransferase (AAT), and enzymes of the transsulfuration pathway.
• Dysregulation of L-cysteine catabolism is linked to oxidative stress, neurological disorders, and cancer.
• Microbial L-cysteine degradation is exploited for industrial fermentation and bioproduction.
• CRISPR knockout, knock-in, and overexpression models enable precise dissection of L-cysteine catabolic gene function.
Description
L-cysteine is a semi-essential sulfur-containing amino acid that plays critical roles in protein structure, redox balance, and metabolism. The catabolic process of L-cysteine, annotated as GO:0019448, encompasses the enzymatic reactions that degrade this amino acid into downstream metabolites such as pyruvate, sulfate, and taurine. This pathway is conserved from bacteria to humans and is vital for maintaining cellular sulfur pools and preventing cysteine toxicity. Understanding L-cysteine catabolism is important for researchers in microbiology, neurology, and cancer biology because its dysregulation contributes to oxidative stress, neurodegeneration, and tumor progression. Moreover, microbial L-cysteine degradation is harnessed for industrial production of valuable compounds. This article provides a comprehensive overview of the genes, mechanisms, and research methods associated with GO:0019448, based on authoritative QuickGO data and verified PubMed literature.
L-cysteine catabolic process At A Glance
| GO ID | GO:0019448 |
|---|---|
| GO term | L-cysteine catabolic process |
| Ontology | biological_process |
| Synonym | L-cysteine breakdown, L-cysteine catabolism, L-cysteine degradation |
| Major function | Breakdown of L-cysteine to regulate sulfur metabolism and redox balance |
| Key enzymes | Cysteine dioxygenase (CDO), aspartate aminotransferase (AAT), cystathionine gamma-lyase (CTH) |
| Pathway context | Transsulfuration, mercapturic acid pathway, taurine biosynthesis |
| Cellular location | Cytoplasm, mitochondria |
| Related diseases | Neurodegeneration, cancer, oxidative stress-related disorders |
What Is GO:0019448?
GO:0019448, L-cysteine catabolic process, is defined as the chemical reactions and pathways resulting in the breakdown of L-cysteine. This biological process includes enzymatic steps that convert L-cysteine into simpler molecules, such as pyruvate, hydrogen sulfide, sulfate, and taurine, thereby regulating sulfur amino acid homeostasis and cellular redox status.
Why Is L-cysteine catabolic process Important in Cell Biology?
L-cysteine catabolism is crucial for maintaining cellular sulfur homeostasis and preventing the accumulation of toxic levels of cysteine, which can lead to oxidative stress and cell death. The pathway produces key metabolites such as taurine, which acts as an antioxidant and neuromodulator, and sulfate, which is essential for detoxification and structural integrity. In microorganisms, L-cysteine degradation is exploited for industrial fermentation to produce valuable compounds like lactic acid. Furthermore, dysregulation of this pathway has been implicated in various human diseases, including anxiety disorders, neurodegenerative diseases, and cancer. Therefore, studying GO:0019448 provides insights into fundamental metabolic regulation and offers potential therapeutic targets.
• Maintains sulfur amino acid homeostasis and prevents cysteine toxicity.
• Produces taurine, a critical antioxidant and neuromodulator.
• Supports detoxification through the mercapturic acid pathway.
• Plays a role in microbial fermentation for industrial biotechnology.
• Dysregulation is linked to oxidative stress and neurological disorders.
• Contributes to cancer metabolism and redox balance.
• Provides targets for metabolic engineering in Escherichia coli.
• Involved in host-pathogen interactions via Neisseria cysteine metabolism.
• Serves as a model for studying enzyme kinetics and regulation.
• Enables CRISPR-based functional genomics of metabolic pathways.
What Happens During L-cysteine catabolic process?
Oxidative Deamination by Cysteine Dioxygenase
In simple terms: The first step often involves adding oxygen to cysteine to make a reactive intermediate.
Cysteine dioxygenase (CDO) catalyzes the oxidation of L-cysteine to cysteine sulfinic acid, a key step in cysteine catabolism. This enzyme is non-heme iron-dependent and regulates cysteine levels to prevent toxicity. In mammals, CDO is highly expressed in the liver and brain, where it controls taurine production.
Transamination and Desulfuration
In simple terms: Cysteine can be converted into other amino acids by transferring its amino group.
Aspartate aminotransferase (AAT) and other transaminases convert L-cysteine to mercaptopyruvate, which is further desulfurated to pyruvate and hydrogen sulfide. This pathway is important for generating pyruvate for energy metabolism and hydrogen sulfide as a signaling molecule.
Transsulfuration Pathway
In simple terms: Cysteine is used to make other sulfur-containing molecules like methionine and glutathione.
The transsulfuration pathway interconverts cysteine and methionine, with cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CTH) catalyzing key reactions. This pathway is essential for glutathione synthesis and redox regulation.
Mercapturic Acid Pathway
In simple terms: Cysteine is used to detoxify harmful substances by forming mercapturic acids.
In the mercapturic acid pathway, cysteine is conjugated to electrophilic compounds, forming mercapturic acids that are excreted in urine. This process is critical for detoxification of drugs and environmental toxins.
Taurine Biosynthesis
In simple terms: Cysteine breakdown leads to taurine, which helps protect cells from damage.
Cysteine sulfinic acid is decarboxylated to hypotaurine, which is then oxidized to taurine. Taurine is a major antioxidant and osmolyte, particularly important in the brain and retina.
Key Genes Involved in GO:0019448 L-cysteine catabolic process
The following genes and proteins are central to the L-cysteine catabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDO1 | Cysteine dioxygenase, oxidizes cysteine to cysteine sulfinic acid | Regulates cysteine levels; implicated in cancer and neurodegeneration |
| AAT | Aspartate aminotransferase, transaminates cysteine to mercaptopyruvate | Links cysteine catabolism to energy metabolism |
| CTH | Cystathionine gamma-lyase, produces cysteine and alpha-ketobutyrate | Key enzyme in transsulfuration and hydrogen sulfide production |
| CBS | Cystathionine beta-synthase, condenses homocysteine and serine to cystathionine | Regulates homocysteine and cysteine homeostasis |
| GOT1 | Glutamic-oxaloacetic transaminase 1, transaminates cysteine | Involved in cysteine catabolism and redox balance |
| GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial transaminase | Contributes to cysteine degradation in mitochondria |
| MPST | Mercaptopyruvate sulfurtransferase, desulfurs mercaptopyruvate | Produces hydrogen sulfide and pyruvate |
| TST | Thiosulfate sulfurtransferase, detoxifies cyanide | Links cysteine catabolism to detoxification |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Uses cysteine for glutathione synthesis |
| GCLM | Glutamate-cysteine ligase modifier subunit | Regulates glutathione synthesis from cysteine |
| SLC7A11 | Cystine/glutamate antiporter | Imports cystine for cysteine synthesis and catabolism |
| SLC3A2 | Cystine/glutamate antiporter subunit | Facilitates cystine uptake for cysteine metabolism |
| NFS1 | Cysteine desulfurase, involved in iron-sulfur cluster biosynthesis | Links cysteine catabolism to cofactor assembly |
| ISCU | Iron-sulfur cluster assembly enzyme | Requires cysteine-derived sulfur |
| SUOX | Sulfite oxidase, oxidizes sulfite to sulfate | Final step in cysteine sulfur catabolism |
| PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | Activates sulfate for detoxification |
| GGT1 | Gamma-glutamyltransferase 1 | Involved in glutathione and cysteine recycling |
How Is L-cysteine catabolic process Regulated?
L-cysteine catabolism is regulated at multiple levels. Cysteine dioxygenase (CDO1) is regulated by its substrate and by changes in cellular redox status. The transsulfuration pathway is controlled by the availability of homocysteine and serine, and by the activity of CBS and CTH. In microorganisms, cysteine degradation is regulated by sulfur availability and by transcriptional regulators such as CysB in Salmonella typhimurium. Additionally, the mercapturic acid pathway is induced by electrophilic stress through Nrf2-mediated transcriptional activation. These regulatory mechanisms ensure that cysteine levels are maintained within a narrow range to support protein synthesis and redox balance while preventing toxicity.
L-cysteine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDO1 | Cancer, neurodegeneration | CRISPR knockout in cancer cell lines; overexpression in neurons |
| CTH | Cancer, cardiovascular disease | Knockout mice; knock-in of point mutations |
| CBS | Homocystinuria, thrombosis | Patient-derived iPSCs; CRISPR correction |
| GCLC | Oxidative stress-related diseases | Knockout cell lines; overexpression studies |
| SLC7A11 | Cancer, ferroptosis | CRISPR knockout; inducible overexpression |
Neurodegenerative Disorders
Dysregulation of L-cysteine catabolism leads to altered taurine and hydrogen sulfide levels, which are implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's. Oxidative stress resulting from impaired cysteine degradation contributes to neuronal damage.
Cancer
Cysteine catabolism supports cancer cell proliferation by providing sulfur for antioxidant defense and biomass. Overexpression of CDO1 and CTH has been observed in various cancers, making them potential therapeutic targets.
Anxiety and Mood Disorders
L-cysteine supplementation has been shown to alleviate anxiety disorders, partly through modulation of cysteine catabolism and glutathione synthesis. The balance between cysteine and its catabolites influences neurotransmitter systems.
Detoxification Defects
Impaired mercapturic acid pathway function due to defective cysteine catabolism can lead to accumulation of toxic electrophiles, increasing susceptibility to drug toxicity and environmental pollutants.
From L-cysteine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CDO1 loss alter cysteine catabolism? | CRISPR knockout in HepG2 cells |
| What is the effect of a CDO1 point mutation on enzyme activity? | CRISPR point mutation knock-in in HEK293T |
| Can CTH overexpression rescue cysteine toxicity? | CRISPR knock-in of CTH under a strong promoter |
| How does tagged CDO1 localize in cells? | CRISPR knock-in of GFP-CD O1 |
| Does SLC7A11 knockout affect cysteine uptake and catabolism? | CRISPR knockout in A549 cells |
| Can CRISPR library screening identify regulators of cysteine catabolism? | Genome-wide CRISPR knockout library in cancer cells |
How to Study the L-cysteine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify transcriptional regulation of cysteine catabolic genes |
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Discover novel regulators of cysteine catabolism |
| LC-MS metabolomics | Metabolite levels (cysteine, taurine, sulfate) | Quantify pathway flux in cells and tissues |
| Enzyme activity assay | Catalytic activity of CDO1, CTH, etc. | Characterize mutant enzymes |
| Western blot | Protein expression levels | Validate knockout or overexpression |
| Immunofluorescence | Subcellular localization | Determine organelle-specific catabolism |
| Isotope tracing | Metabolic flux | Track cysteine-derived carbon and sulfur |
| CRISPR library screening | Pooled gene function | Identify synthetic lethal interactions |
Genomic and Transcriptomic Approaches
RNA-seq and CRISPR screening can identify genes involved in L-cysteine catabolism and their regulators. Transcriptomic profiling of cells under cysteine deprivation reveals adaptive responses.
Proteomic and Metabolomic Profiling
Mass spectrometry-based proteomics and metabolomics quantify enzymes and metabolites of the cysteine catabolic pathway, such as cysteine sulfinic acid and taurine.
Enzymatic Activity Assays
In vitro assays using recombinant CDO1, CTH, and other enzymes measure catalytic activity and kinetics, providing insights into regulation.
Imaging and Flux Analysis
Fluorescent probes and isotope tracing (e.g., 34S-cysteine) allow real-time monitoring of cysteine catabolism in live cells and tissues.
How CRISPR Can Be Used to Study GO:0019448 L-cysteine catabolic process
Knockout
CRISPR knockout of genes such as CDO1, CTH, or SLC7A11 enables loss-of-function studies to determine their role in L-cysteine catabolism and downstream phenotypes. Knockout cell lines can be used to assess cysteine toxicity, redox balance, and metabolic reprogramming.
Point Mutation
Introducing specific point mutations (e.g., in the catalytic site of CDO1) via CRISPR knock-in allows precise structure-function analysis of enzymes involved in cysteine catabolism. This approach can model human disease-associated variants.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of catabolic enzymes facilitates localization, interaction, and degradation studies. Knock-in of reporter genes under endogenous promoters provides physiological expression patterns.
Overexpression
CRISPR activation (CRISPRa) or knock-in of strong promoters can overexpress genes like CTH or CDO1 to study their effects on cysteine catabolism and cellular resistance to oxidative stress. Overexpression models are useful for drug screening and pathway flux analysis.
How EDITGENE Supports L-cysteine catabolic process Research
Researchers studying L-cysteine catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, metabolite production, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for L-cysteine catabolic process research.
Frequently Asked Questions About L-cysteine catabolic process
What is L-cysteine catabolic process?
L-cysteine catabolic process (GO:0019448) is the set of biochemical reactions that break down L-cysteine into metabolites such as pyruvate, sulfate, and taurine.
What genes are involved in L-cysteine catabolic process?
Key genes include CDO1, CTH, CBS, AAT, MPST, and SLC7A11, among others.
Why is L-cysteine catabolism important?
It maintains sulfur homeostasis, prevents cysteine toxicity, produces antioxidants like taurine, and supports detoxification.
How is L-cysteine catabolic process regulated?
It is regulated by substrate availability, redox status, and transcriptional factors such as Nrf2 and CysB.
What diseases are associated with L-cysteine catabolism?
Dysregulation is linked to neurodegenerative diseases, cancer, anxiety disorders, and detoxification defects.
What methods are used to study L-cysteine catabolic process?
Common methods include CRISPR screening, RNA-seq, metabolomics, enzyme activity assays, and isotope tracing.
Can CRISPR be used to study L-cysteine catabolism?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise functional studies of genes in this pathway.
What is the role of cysteine dioxygenase in L-cysteine catabolism?
Cysteine dioxygenase (CDO1) catalyzes the first step of cysteine catabolism, converting cysteine to cysteine sulfinic acid.
How does L-cysteine catabolism affect cancer?
It supports cancer cell antioxidant defense and proliferation, making it a potential therapeutic target.
What is the mercapturic acid pathway?
The mercapturic acid pathway is a detoxification route that conjugates cysteine to electrophiles for excretion.
Conclusion
L-cysteine catabolic process (GO:0019448) is a fundamental metabolic pathway with far-reaching implications for cellular redox balance, sulfur homeostasis, and human health. Its dysregulation contributes to neurological disorders, cancer, and detoxification defects, while microbial cysteine catabolism is exploited for industrial biotechnology. Advances in CRISPR-based models and multi-omics technologies are accelerating our understanding of this pathway, offering new opportunities for therapeutic intervention and metabolic engineering. EDITGENE stands ready to support researchers with tailored CRISPR solutions to dissect the genes and mechanisms of L-cysteine catabolism.
References
- 1. Takagi H et al.. 2017. L-Cysteine Metabolism and Fermentation in Microorganisms.. Adv Biochem Eng Biotechnol 159:129-151 PMID: 27872962
- 2. Caballero Cerbon DA et al.. 2024. Metabolic control analysis enabled the improvement of the L-cysteine production process with Escherichia coli.. Appl Microbiol Biotechnol 108(1):108 PMID: 38212968
- 3. Salyha N et al.. 2018. Protective role of l-glutamic acid and l-cysteine in mitigation the chlorpyrifos-induced oxidative stress in rats.. Environ Toxicol Pharmacol 64:155-163 PMID: 30412861
- 4. Liu RX et al.. 2024. L-Cysteine: A promising nutritional supplement for alleviating anxiety disorders.. Neuroscience 555:213-221 PMID: 39089569
- 5. Li Y et al.. 2023. Enhancement effect of l-cysteine on lactic acid fermentation production.. Biotechnol J 18(12):e2300110 PMID: 37533375
- 6. Kredich NM et al.. 1979. Synthesis of L-cysteine in Salmonella typhimurium.. Ciba Found Symp PMID: 398768
- 7. Hicks JL et al.. 2018. Cysteine biosynthesis in Neisseria species.. Microbiology (Reading) 164(12):1471-1480 PMID: 30307392
- 8. Hanna PE et al.. 2019. The mercapturic acid pathway.. Crit Rev Toxicol 49(10):819-929 PMID: 31944156
